Coltene Holding AG

Coltene Holding AG

CLTN · SW · Healthcare / Medical Instruments & Supplies

47.95CHF-0.50 (-1.03%)

Price History

Full chart

Market Stats

Previous Close48.45
Open48.25
Day Range47.90 – 48.65
52-Week Range42.37 – 58.68
Volume1.45K
Market Cap278.45M
P/E (TTM)18.64
Forward P/E14.45
EPS2.50
Dividend Yield4.29%
Beta0.84
50-Day Avg47.74
200-Day Avg50.62

About

COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. The company offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, characterizations, and parapulpal pins; and endodontics products, such as cold sprays, hand files, shaping and retreatment files, endo motors, rinsing and disinfection system, drying, temporary fillings, sealers, guttapercha points, and posts and drills. It also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consist of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verification products. In addition, the company offers infection control products, which include ultrasonic cleaning solutions, patient bibs, instrument reprocessing, and surface disinfectants; rotary instruments that comprise diamond and carbide burs, polishers, kits, and accessories; and laboratory products, including gingiva masks, lab putty products, model making products, waxes, occlusion control products, and accessories. Further, it provides adhesives, root canal instruments, irrigation solutions, and materials for root canal obturation and sealing; impression materials, wound care and cotton wool products, suction cannulas, rotary instruments, and rubber dams for isolating the treatment area; and thermal disinfectors, washers, cleaning and disinfecting wipes, and autoclaves. The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008. COLTENE Holding AG was incorporated in 2005 and is headquartered in Altstätten, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Dominik Arnold
  • Employees1.14K
  • HeadquartersFeldwiesenstrasse 20, Altstätten, Switzerland, 9450, Switzerland
  • Websitehttps://www.coltene.com

Leadership

  • Mr. Dominik ArnoldChief Executive Officer · b. 1972
  • Mr. Markus AbderhaldenChief Financial Officer · b. 1979
  • Mr. Gregor PicardChief Operating Officer · b. 1970
  • Patrick BayerChief Marketing Officer · b. 1986
  • Mr. Di HuVice President of Sales & Marketing Communication EU&ROW (CSO) · b. 1977

Financials

Income Statement

Currency: CHF2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue218.90M246.89M249.86M274.23M166.42M151.38M153.58M146.13M158.07M160.01M162.35M154.50M160.66M167.99M203.95M273.83M248.35M279.24M267.13M242.73M250.16M240.05M
Growth (%)-+12.79%+1.21%+9.75%-39.31%-9.03%+1.45%-4.85%+8.17%+1.22%+1.46%-4.84%+3.99%+4.56%+21.41%+34.26%-9.30%+12.44%-4.34%-9.13%+3.06%-4.04%
Cost of Revenue154.20M83.40M82.56M88.72M45.70M43.15M44.11M44.49M46.78M47.74M48.20M47.19M45.60M47.92M63.26M95.66M96.92M102.12M98.71M183.06M93.20M178.50M
Gross Profit64.70M163.49M167.30M185.51M120.72M108.24M109.47M101.64M111.29M112.28M114.15M107.31M115.06M120.07M140.70M178.17M160.46M177.12M168.41M59.67M156.96M61.55M
Gross Margin29.56%66.22%66.96%67.65%72.54%71.50%71.28%69.55%70.40%70.17%70.31%69.46%71.61%71.47%68.99%65.07%64.61%63.43%63.05%24.58%62.74%25.64%
Operating Expense44.40M136.30M137.22M150.28M95.80M87.90M91.02M89.39M94.27M92.83M91.75M86.92M91.75M94.58M117.02M146.16M137.20M133.33M133.50M40.06M130.12M41.06M
Operating Income20.30M27.18M30.08M35.23M24.92M20.34M18.44M12.25M17.02M19.45M22.41M20.39M23.31M25.48M23.68M32.01M23.26M43.80M34.91M19.61M26.84M20.49M
Operating Margin9.27%11.01%12.04%12.85%14.98%13.43%12.01%8.38%10.77%12.15%13.80%13.19%14.51%15.17%11.61%11.69%9.37%15.68%13.07%8.08%10.73%8.53%
EBITDA34.00M31.34M41.95M30.25M27.44M25.13M18.67M15.13M21.38M23.07M27.09M25.87M29.41M31.19M30.94M35.02M26.48M48.05M39.88M23.80M34.23M27.70M
EBITDA Margin15.53%12.69%16.79%11.03%16.49%16.60%12.16%10.35%13.53%14.42%16.69%16.75%18.30%18.57%15.17%12.79%10.66%17.21%14.93%9.81%13.68%11.54%
Net Income13.31M18.12M22.64M26.30M48.07M16.36M9.29M5.99M9.53M13.19M15.63M13.34M17.27M19.06M14.91M20.03M8.23M31.71M26.00M11.95M20.47M14.94M
Net Income Margin6.08%7.34%9.06%9.59%28.88%10.80%6.05%4.10%6.03%8.24%9.63%8.63%10.75%11.35%7.31%7.32%3.31%11.36%9.73%4.92%8.18%6.23%
R&D---------4.12M5.35M4.47M4.70M5.29M8.15M10.89M9.46M9.05M8.57M9.88M-8.34M
R&D as % of Total Revenue---------2.57%3.29%2.89%2.93%3.15%4.00%3.98%3.81%3.24%3.21%4.07%-3.48%
Interest Expense4.40M8.60M9.27M4.75M2.73M372.00K2.68M3.34M1.13M879.00K958.00K563.00K343.00K302.00K435.00K781.00K795.00K415.00K232.00K837.00K854.00K511.00K
Interest Expense % of Total Revenue2.01%3.48%3.71%1.73%1.64%0.25%1.74%2.29%0.72%0.55%0.59%0.36%0.21%0.18%0.21%0.29%0.32%0.15%0.09%0.34%0.34%0.21%

Balance Sheet

Currency: CHF2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets248.63M253.97M247.40M247.57M161.47M157.18M158.69M149.89M152.76M146.86M164.65M149.19M160.39M167.31M420.22M189.83M187.63M186.74M190.60M175.42M186.95M184.83M
Total Liabilities155.48M122.59M98.20M81.90M48.31M46.45M60.84M55.30M55.90M49.21M60.53M47.61M48.14M45.61M124.05M98.62M97.40M79.34M78.41M78.55M78.15M84.30M
Total Equity93.15M131.38M149.20M165.66M113.16M110.73M97.85M94.59M96.86M97.65M104.12M101.58M112.25M121.70M296.17M91.21M90.23M107.40M112.18M96.87M108.80M100.53M
Cash21.38M25.75M19.95M13.37M11.12M5.88M4.13M3.13M4.00M6.51M18.28M14.64M21.57M22.04M20.90M22.96M38.47M25.73M24.22M18.36M21.86M20.66M
Total Debt110.43M11.50M31.89M36.55M2.64M22.88M34.07M30.18M-16.83M20.80M13.78M12.92M8.28M50.06M59.80M60.34M42.92M47.07M45.00M40.00M47.00M
Net Debt89.06M-14.24M11.94M23.19M-8.48M17.00M29.94M27.05M-4.00M10.32M2.52M-864.00K-8.65M-13.76M25.09M36.83M21.87M17.18M22.85M26.64M18.14M26.34M

Cash Flow

Currency: CHF2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow17.46M18.87M31.36M29.04M20.14M25.35M14.17M14.58M12.74M23.28M19.94M18.16M22.68M21.89M24.63M23.79M34.81M32.52M23.42M25.98M28.56M13.78M
Investing Cash Flow-8.35M6.25M5.88M-15.37M86.51M-16.69M-9.37M-4.64M-4.62M-6.29M-3.25M-4.45M-5.61M-5.87M-115.44M-13.07M-10.52M-9.79M-8.20M-8.56M-8.53M-5.66M
Financing Cash Flow-6.83M23.04M30.75M-20.11M-108.07M-13.88M-6.29M-10.83M-7.18M-14.35M-5.10M-17.17M-10.11M-15.66M89.95M-8.35M-8.08M-35.83M-15.93M-21.93M-17.07M-8.18M
Capital Expenditure3.78M4.57M5.45M6.20M6.37M7.53M3.44M4.67M4.69M6.35M3.60M4.51M5.74M4.40M12.98M13.30M9.47M9.90M8.32M8.68M5.75M4.60M
Free Cash Flow13.68M14.30M25.91M22.84M13.77M17.82M10.73M9.92M8.05M16.93M16.34M13.65M16.94M17.50M11.65M10.49M25.34M22.61M15.10M17.29M22.82M9.17M
Dividends Paid-7.34M-7.41M19.56M17.84M12.86M-4.63M7.59M9.28M10.55M9.28M11.38M12.65M17.92M8.96M17.92M19.72M19.71M11.95M14.93M
FCF to OCF78.35%75.79%82.63%78.66%68.36%70.28%75.75%68.00%63.17%72.73%81.96%75.15%74.70%79.91%47.32%44.09%72.79%69.54%64.48%66.57%79.89%66.60%
Dividend Paid to FCF-51.32%-32.45%142.05%100.11%119.81%-57.53%44.84%56.80%77.27%54.76%65.05%108.58%170.92%35.38%79.27%130.54%113.99%52.36%162.72%

Earnings

Report DateMar 3, 2016Aug 5, 2016Mar 9, 2017Aug 4, 2017Mar 6, 2018May 30, 2018Aug 22, 2018Oct 31, 2018Apr 4, 2019Aug 22, 2019Oct 30, 2019Mar 5, 2020Jun 3, 2020Aug 7, 2020Oct 28, 2020Mar 5, 2021Jun 2, 2021Aug 6, 2021Nov 3, 2021Mar 4, 2022Jun 1, 2022Aug 5, 2022Nov 2, 2022Mar 3, 2023May 31, 2023Aug 4, 2023Nov 1, 2023Mar 8, 2024May 29, 2024Aug 8, 2024Nov 18, 2024Mar 7, 2025Jul 25, 2025Mar 5, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00-0.00-0.000.000.000.000.000.000.000.00--
EPS Actual2.281.702.401.433.090.001.650.001.541.330.002.020.000.050.001.290.003.040.002.270.002.030.002.320.000.000.000.000.000.000.001.690.71-
Surprise----------------------------------
Timing-------------------Pre-market-Pre-market-Pre-market-After-hours------After-hoursPre-market

Key Statistics & Ratios

Market Cap278.45M
Enterprise Value300.01M
Trailing P/E18.64
Forward P/E14.45
PEG Ratio4.34
Price / Sales1.19
Price / Book2.94
EPS2.50
Book Value15.58
Revenue (TTM)234.80M
Gross Profit (TTM)152.03M
EBITDA25.03M
Profit Margin6.27%
Operating Margin5.10%
Return on Equity16.04%
Return on Assets6.57%
Shares Outstanding5.98M
Shares Float2.58M
Beta0.84
Dividend Yield4.29%
Dividend Rate2.00
Payout Ratio80.97%

Dividends

20261×
0.28Apr 23, 2026
20251×
2.50Apr 25, 2025
20241×
2.00Apr 19, 2024
20231×
3.30Apr 21, 2023
20221×
3.30Apr 25, 2022
20211×
3.00Apr 6, 2021
20201×
1.50Apr 6, 2020
20191×
3.00May 3, 2019
20181×
2.98Apr 4, 2018
20171×
2.68Mar 31, 2017
20161×
2.19Apr 1, 2016
20151×
2.48Mar 27, 2015
20141×
0.28Apr 17, 2014
20131×
1.79Apr 17, 2013
20121×
1.09Apr 24, 2012
20111×
1.74May 2, 2011
20101×
3.08Apr 30, 2010
20091×
4.27Apr 22, 2009
20082×
4.87Jul 14, 20084.27Apr 21, 2008
20071×
1.59Apr 24, 2007

Stock Splits

  • Sep 19, 2018147:146